All sophisticated investors should sincerely think of diversifying your portfolio with recovery plays
The top pick is Genting Berhad
Catalysts:
Vaccine FDA EUA (emergency use authorisation) and Full Approval Vaccine roll outs (UK, Russia; imminent US etc) Year end / CNY rally and Super Cycle Vaccine Malaysia approval/supply agreement/delivery/administering Resorts World Las Vegas & Resorts World Genting Theme Park US & Bahamas and UK & Egypt revivalWHO / COVAX approves and distributes vaccines WHO declares pandemic over Border opening / international visitors Genting Plantations (CPO record high) Genting Power, Property, Oil & Gas (cyclical sector in an upcycle)
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
Calling on anyone reading this, please understand that the backbone of any economy is the common man. If you take away the ability of the common man to contribute to the economic activity of the nation, the economy will sink over time. You will see joblessness, poverty, hunger and everythuing that we and our founding fathers hoped will never come to pass.
BOYCOTT ALL BANKS, INVESTMENT BANKS THAT ISSUE STRUCTURED WARRANTS
Today Top Glove released its 1QFY2021 report. You can access the full report here.
The stock has been trading at below RM7 level for the better part of the last few weeks on a myriad of news perceived as bad. Albeit all that, the company posted a net profit of RM2.38 billion for the quarter. They have approximately 8.2 billion outstanding shares. This gives the company an EPS of RM0.29 for the quarter. Let's do a bit of calculating:
- Assume the profits don't increase (they are expected to, but we will be conservative).
- This would mean an EPS of RM1.16 for FY2021.
- This translates into a forward P/E of 6 at price RM7 (as of writing this, the price is RM6.84)
This make is one of the lowest valued stocks in the entire stock market, with only 5 companies having forward P/Es of below 6 at the time of writing this.
If we assume that a stock is fairly priced at P/E 15, this would mean that the fair value of Top Glove is RM17.40.
At the same time, one of Top Glove's main competitors in the glove manufacturing market - Hartalega, has a consensus forward P/E of about 19.5 based on its current market price.
Let's assume that the market assigns the same valuation to Top Glove as it does to its direct competitor and simiarly-sized peer Hartalega. In this case, Top Glove's market price would be RM22.62.
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
dumbdumb123
150 posts
Posted by dumbdumb123 > 2020-12-08 22:21 | Report Abuse
You don’t need gloves to give an injection. But you need gloves for lots of other things you do.